Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgery

Project description

Innovative imaging platform for effective removal of cancerous tissue

Effective removal of cancerous tissue by endoscopic surgery is challenging, partially because of the difficulty of differentiation of tissue types with current imaging technologies. Thericon in Germany is developing a real-time multispectral imaging platform with multiparametric images to assist in the effective removal of cancerous tissue and the reduction of cancer recurrence in patients. The company has developed a prototype device and completed initial validation in bladder cancer applications. The EU-funded rMSI project aims to complete clinical application studies, safety tests and certification of the final product in preparation for marketing.

Objective

Cancer is the leading cause of death in the EU, with 2.7M diagnoses and 1.3M deaths in 2020. Effective removal of cancerous tissue through endoscopic surgery is challenging because of limited visual and absent tactile information, along the limitations of current imaging technologies, which make it difficult for surgeons to differentiate between different types of tissue. For this market, Thericon is developing an rMSI (real-time multispectral imaging) platform providing surgeons with multi-parametric images that help with effective removal of cancerous tissue and reduction of cancer recurrence in patients. The company has developed a prototype for its first product, named rMSI 2, and completed initial validation for bladder cancer applications. Thericon is asking for a 2.5M EIC grant and 5.5M equity funding to complete clinical application pilots, safety tests and CE certification for this product, getting it ready for market launch in 2024.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

THERICON GMBH
Net EU contribution
€ 2 500 000,00
Address
CUBEX41, UNIVERSITATSMEDIZIN MANNHEIM THEODOR-KUTZER-UFER 1-3
68167 Mannheim
Germany
SME
Yes
Region
Baden-Württemberg Karlsruhe Mannheim, Stadtkreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 4 092 151,25